CRP and Increased total eosinophil count: Prior to the fifth dose, bowel movements had decreased to 3–5 loose stools per day, and abdominal pain had resolved, but hemoglobin dropped 6.8 g/dL, eosinophilia persisted, and platelet count rose to 521 × 103/μL; CRP was within normal limits.